Horseshoe crab amebocyte lysate factor G activation inhibitor
First Claim
Patent Images
1. A method of inhibiting the activation of factor G contained in horseshoe crab amebocyte lysate, which comprises adding to horseshoe crab amebocyte lysate a polyglycoside comprising a poly-(1→
- 3)-β
-D-glucoside structural portion consisting of 2 to 370 (1→
3)-β
-D-glucoside structural units of the following formula;
##STR16## which are continuously bound to one another, in an amount effective to inhibit the activation of factor G.
1 Assignment
0 Petitions
Accused Products
Abstract
This invention relates to a horseshoe crab amebocyte lysate factor G activation inhibitor comprising as an active ingredient a polyglycoside containing at least one poly-(1→3)-β-D-glucoside structure portion consisting of 2 to 370 (1→3)-β-D-glucoside structural units of the following formula ##STR1## which are continuously bound to one another. This inhibitor is useful for inhibiting the activation of factor G which may exist in horseshoe crab amebocyte lysate used in the Limulus test.
-
Citations
18 Claims
-
1. A method of inhibiting the activation of factor G contained in horseshoe crab amebocyte lysate, which comprises adding to horseshoe crab amebocyte lysate a polyglycoside comprising a poly-(1→
- 3)-β
-D-glucoside structural portion consisting of 2 to 370 (1→
3)-β
-D-glucoside structural units of the following formula;
##STR16## which are continuously bound to one another, in an amount effective to inhibit the activation of factor G. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)
- 3)-β
Specification